Phase 4 Type 1 Diabetes Trial, Recruiting NCT06706284 Sponsor: Marzieh Salehi Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Phase 4 Type 1 Diabetes Trial, Recruiting

NCT06706284
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old (inclusive)
  • It has been more than one year since your spinal cord injury
  • Your spinal cord injury is at a level between C2 and L2, with any level of impairment on the standard injury scale (A, B, C, or D)
  • You are willing and able to sign a consent form before any study activities begin
  • You have been diagnosed with Type 2 diabetes, and your blood sugar is managed only with diet and the medication metformin, with no major dose changes in the last three months
  • Your HbA1c (a measure of average blood sugar over time) is between 6.0% and 9.0% at the screening visit
  • Your BMI (body mass index) is above 22 kg/m²
  • If you are a woman who could become pregnant, you must have a negative pregnancy test at the start of the study and are not currently breastfeeding
  • If you are a woman who could become pregnant and are sexually active with a male partner who has not been sterilised, you must use at least one reliable form of contraception throughout the study (note: rhythm method, periodic abstinence, and withdrawal are not accepted as suitable methods)

Who may not be able to join:

  • You have any existing health condition that, in the opinion of the study doctor, could interfere with the study, put you at risk, or affect the results
  • You have taken part in another clinical trial in the last 30 days (or longer, depending on the drug used)
  • You are currently taking mirabegron or any other medications that affect blood sugar levels
  • You have taken steroid medications at any point in the past year
  • You have significant anaemia (low red blood cell levels, specifically haemoglobin below 11g/dL)
  • You have a history of a blockage in your stomach outlet or long-term (chronic) diarrhoea
  • You have a chronic neurological condition other than your spinal cord injury (for example, multiple sclerosis)
  • You have taken certain weight-loss or appetite-control medications within the past year, or certain diabetes medications (such as pioglitazone, SGLT2 inhibitors, DPPIV inhibitors, or GLP-1 medications) within the past 60 days
  • You have a serious allergy or sensitivity to any of the study treatments or to paracetamol (acetaminophen)
  • You have symptoms of severely uncontrolled blood sugar (such as extreme thirst, frequent urination, or unexplained weight loss), a history of Type 1 diabetes or diabetic ketoacidosis, or have used daily insulin injections within the past 90 days
  • You have significant inflammatory bowel disease or have had major surgery on your upper digestive tract (note: prior weight-loss/bariatric surgery is not automatically excluded — confirm with trial site)
  • You have a history of acute or chronic pancreatitis (inflammation of the pancreas)
  • You have significant liver disease (certain liver conditions may still be acceptable — confirm with trial site), or your liver function blood test results are significantly above the normal range at screening
  • Your kidney function is reduced below a certain level (eGFR below 45 mL/minute/1.73m²) at screening
  • You have had a heart attack, unstable chest pain, mini-stroke, or stroke in the last 3 months, or have had certain heart procedures in the last 6 months
  • You have severe heart failure (classified as New York Heart Association Class III or IV)
  • You have elevated calcitonin levels in your blood, or a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma) or a related condition (multiple endocrine neoplasia)
  • You have had cancer in the last 5 years (some minor skin cancers or cervical cancer in situ may be exceptions — confirm with trial site)
  • You have a history of HIV or another condition that significantly weakens your immune system, or you have had an organ transplant
  • You have a history of substance dependence, alcohol abuse, or regularly drink excessive amounts of alcohol
  • You are currently following a ketogenic (very low carbohydrate) diet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Marzieh Salehi, MD, The University of Texas Health Science Center at San Antonio

Phone: 210-567-6691

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Marzieh Salehi
Registry
ClinicalTrials.gov
Start date
11 April 2025
Est. completion
1 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Glucose tolerance; Insulin action

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov